Guest guest Posted December 26, 2010 Report Posted December 26, 2010 Lily,I think your questions are important enough for all of us to consider.I hope that I do not offend anyone by my language or tone, it is not my intention.Scientific inquiry is largely based on assumptions. These assumptions may not be valid or even accurate. They may be by and large based on the political policies of the funding source. (Not too long ago the CDC's HIV prevention campaigns supported abstinence over condoms. Which interest group won? Abstinence. How many cases of HIV infection could have been prevented if condoms were promoted over abstinence? I could only imagine it.)Anal sex is synonymous with gay sex in many circles. We are all familiar with the slang terms of "Top" and "Bottom," that are mostly used when talking about inserting penis into rectum. Sadly, the statistics of heterosexual folks that participate in anal activities is either unknown or unchallenged. Men, in general, prefer a tighter body cavity regardless of their sexual orientation.Look at the heartbreaking story of Farrah Fawcett who died of a cancer that could have easily been prevented. If only she have had a regular anal pap smear. It is not in the medical profession's radar just yet to routinely tests the rectal area of women or men. We, the patients, are partly to blame when we discuss sex practices with our health providers. You would be surprised at how many men are not upfront about their proclivities/concerns with their medical establishment. Hopefully, gay health activists would make this a pressing concern for ALL the rest of us. By the look at this FDA's decision, it seems that the tide is changing.One other fact that we need to take into account is that participation rates for women in clinical trials have been historically low and under-represented. This is because of possible birth defects, lawsuits, socio-economic status, education, caring for children, etc. There are volumes written about the gender-gap in drug trials. According to the Canadian Broadcasting Corporation, less than 25% of women participate in drug trials.Here is the link in case you want it for the CBC article:http://www.cbc.ca/health/story/2010/06/10/gender-bias-medical-research.html Quote
Guest guest Posted December 26, 2010 Report Posted December 26, 2010 "Can someone tell me why they don't include women (say older than 26) in all this anal, and vaginal infection??? Is no one aware that this effects women as much as men, gay men, young girls..etc. "Lily,Most of the early research was done on girls for a couple of reasons. First, the rate of HPV infection is so high, like 70% of the population, that if you're going to do prevention trials, you have to catch populations with the lowest rate of sexual partners, preferably zero. So, you start with the youngest girls you can, and work from there. Second, men were not looked at, at all, in early trials. There is a "chicken/egg" argument about boys infecting girls, so girls were looked at first. Under the Bush administration, research that mentioned "MSM, Gay men, etc," was not funded.In older populations, much of which is already infected, the usefulness of gardasil is not understood. It might help, it might do nothing. It probably can't hurt. JB Quote
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.